dichlororibofuranosylbenzimidazole has been researched along with Chondromalacia in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Chondromalacia: Softening and degeneration of the CARTILAGE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Primorac, D | 1 |
| Johnson, CV | 1 |
| Lawrence, JB | 1 |
| McKinstry, MB | 1 |
| Stover, ML | 1 |
| Schanfield, MS | 1 |
| Andjelinovic, S | 1 |
| Tadic, T | 1 |
| Rowe, DW | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Chondromalacia
| Article | Year |
|---|---|
Premature termination codon in the aggrecan gene of nanomelia and its influence on mRNA transport and stability.
Topics: Aggrecans; Animals; Cartilage; Cartilage Diseases; Cell Culture Techniques; Chick Embryo; Chondrocyt | 1999 |